Myovant Sciences Ltd. Net Change in Cash
Myovant Sciences Ltd. reported Net Change in Cash of -$160.05 million for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-01-26
- Myovant Sciences Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-06-30 was -$80.56M.
- Myovant Sciences Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-06-30 was -$183.43M, a 2369.65% decline year-over-year.
- Myovant Sciences Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-06-30 was $8.08M, a 88.56% decline year-over-year.
- Myovant Sciences Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-06-30 was $70.66M, a 101.82% increase year-over-year.
- Myovant Sciences Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$260.68M, a 143.48% decline from fiscal 2021.
- Myovant Sciences Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $599.46M.
- Myovant Sciences Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was -$79.18M, a 263.01% decline from fiscal 2019.
- Myovant Sciences Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $48.58M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$160.05M 10-Q · filed 2023-01-26 | |||
| 2022-09-30 | -$63.98M 10-Q · filed 2022-10-26 | |||
| 2022-06-30 | -$80.56M 10-Q · filed 2022-07-27 | |||
| 2022-03-31 | -$260.68M 10-K · filed 2022-05-11 | |||
| 2021-12-31 | -$209.64M 10-Q · filed 2023-01-26 | |||
| 2021-09-30 | -$149.22M 10-Q · filed 2022-10-26 | |||
| 2021-06-30 | -$183.43M 10-Q · filed 2022-07-27 | |||
| 2021-03-31 | $599.46M 10-K · filed 2022-05-11 | |||
| 2020-12-31 | $638.49M 10-Q · filed 2022-01-26 | |||
| 2020-09-30 | $18.18M 10-Q · filed 2021-10-26 | |||
| 2020-06-30 | $8.08M 10-Q · filed 2021-07-28 | |||
| 2020-03-31 | -$79.18M 10-K · filed 2022-05-11 | |||
| 2019-12-31 | -$72.75M 10-Q · filed 2021-02-11 | |||
| 2019-09-30 | -$25.45M 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | $70.66M 10-Q · filed 2020-08-11 | |||
| 2019-03-31 | $48.58M 10-K · filed 2021-05-11 | |||
| 2018-12-31 | $74.98M 10-Q · filed 2020-02-10 | |||
| 2018-09-30 | $45.69M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $35.01M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | -$72.21M 10-K · filed 2020-05-18 | |||
| 2017-12-31 | -$51.97M 10-Q · filed 2019-02-07 | |||
| 2017-03-31 | $180.84M 10-K · filed 2019-05-24 |